Biotech Values

[isolution]

the iHub poster who probably knows more about AMD than anybody here (but unfortunately has gone MIA) is isolution

Dew, thank for your appreciation, I appreciate and I return the compliment for your bright and accurate analysis of companies working on AMD (and other markets...glaucoma for instance).
Exceptionnally this time you've been wrong, I am still there.

I am xtremely busy at the moment and that is the reason for my silence.

I can confirm that almost all Co's in Phase I/II or II are desperatly seeking a non-systemic way to administer AMD drugs, except, to my knowledge, Genaera. Your analysis about 10mg dose is right, either there is side-effects (the probability of long term side-effect could be high), or if 10mg is sufficient, why not use that dose.

I'll try to do my best to be more active on that board in the future.

Regards